4//SEC Filing
SOLAZYME INC 4
Accession 0001555667-16-000057
CIK 0001311230operating
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 8:30 PM ET
Size
9.3 KB
Accession
0001555667-16-000057
Insider Transaction Report
Form 4
SOLAZYME INCSZYM
Licari Peter
EVP, Research & Development
Transactions
- Award
Common Stock
2016-03-08+50,000→ 220,843 total - Sale
Common Stock
2016-03-08$1.66/sh−1,562$2,598→ 170,843 total - Award
Employee Stock Option (right to buy)
2016-03-08+275,000→ 275,000 totalExercise: $1.66Exp: 2026-03-07→ Common Stock (275,000 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was designed to cover tax withholding obligations in connection with the concurrent vesting of restricted stock units.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.63 to $1.69, inclusive. The reporting person undertakes to provide to Solazyme, Inc., any security holder of Solazyme, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The grant shall vest as to 1/4 of the shares on March 9, 2017 and thereafter shall vest as to 1/8 of the shares on each of September 14, 2017, March 8, 2018, September 14, 2018, March 1, 2019, September 11, 2019 and March 11, 2020.
- [F4]The option shall vest as to 1/48 of the underlying shares monthly beginning February 1, 2016.
Documents
Issuer
SOLAZYME INC
CIK 0001311230
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001311230
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 8:30 PM ET
- Size
- 9.3 KB